For the first time, data from real-world application of psilocybin treatment under a regulated program was published by one of the Oregon clinics providing treatment.
Professor David Nutt stands out as a leading figure in modern psychedelic science, tirelessly pushing the boundaries of how drugs such as psilocybin, MDMA, LSD, DMT,...
On Friday, the Royal College of Psychiatrists has published a new report assessing the safety and efficacy of psychedelics and related substances as treatments for mental...
Psychedelic medicine took a major step forward this month as JAMA published results from the first randomized, placebo-controlled trial of LSD for anxiety.
A new article published in Nature by Dr.
AbbVie Inc.
By Jody Chu and James Bunn.
After a ten-month pause, Psychedelic Health returns — renewed in purpose and ready to stand with an industry that has faced some of its most challenging...
In recent years, the UK has seen a resurgence in interest and investment in psychedelic research, particularly focusing on substances like psilocybin and MDMA.
The past year featured some of Britain’s most significant landmarks in advancing access to psychedelic medicine.
A newly published academic review has revisited one of the most sensational — and disputed — theories in psychedelic history: that early Christianity emerged from fertility...
A trend towards the legalization of psychedelic substances for medical use continues across the English-speaking world.
